Clinical trial

Study of a Flu Vaccine in Children

NCT00001127 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00001127
Title Study of a Flu Vaccine in Children
Official title Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Aviron LLC Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Influenza
Intervention type Biological
Interventions Influenza virus vaccine (CAIV-T)
Enrollment 15,000
Completion Nov 1, 2005
First posted Aug 31, 2001
Last update posted Aug 27, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies